,i #aafth ,,congress #b;d ,session ,h4 ,r4 #ehfg ,,in ,,the ,,house ,,of ,,representatives ,february #ab1 #bjbj,mr4 ,cisneros 7for himself and ,mr4 ,mast7 introduced the following bill2 which was referred to the ,committee on ,veterans' ,affairs1 and in addition to the ,committees on ,armed ,services1 and ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to direct the ,secretary of ,veterans ,affairs to establish or update certain clinical practice guidelines of the ,department of ,veterans ,affairs1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,setting ,treatment ,options and ,practices for ,veteran ,suicide and ,substance ,abuse ,act or the ,,stop ,veteran ,suicide and ,substance ,abuse ,act4 #b4 ,establishment by ,department of ,veterans ,affairs and ,department of ,defense of clinical practice guidelines for comorbid mental health conditions such as ,,ptsd1 ,,mst1 and_/or ,,tbi 7a7 ,in general ,not later than two years after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs1 in consultation with the ,secretary of ,defense and the ,secretary of ,health and ,human ,services1 shall complete the development of clinical practice guidelines for the treatment of post-traumatic stress disorder1 military sexual trauma1 and traumatic brain injury that is comorbid with substance use disorder or chronic pain4 7b7 ,work group 7#a7 ,establishment ,in carrying out subsection 7a71 the ,secretary of ,veterans ,affairs1 the ,secretary of ,defense1 and the ,secretary of ,health and ,human ,services shall create a ,trauma and ,comorbid ,substance ,use ,disorder or ,chronic ,pain ,work ,group 7in this section referred to as the ,work ,group74 7#b7 ,membership ,the work group created under paragraph 7#a7 shall be comprised of individuals that represent ,federal ,government entities and non-,federal ,government entities with expertise in the areas covered by the work group1 including the following3 7,a7 ,academic institutions that specialize in research for the treatment of conditions described in subsection 7a74 7,b7 ,the ,national ,center for ,posttraumatic ,stress ,disorder of the ,department of ,veterans ,affairs4 7,c7 ,the ,office of the ,assistant ,secretary for ,mental ,health and ,substance ,use of the ,department of ,health and ,human ,services4 7#c7 ,relation to other work groups ,the ,work ,group shall be created and conducted in the same manner as other work groups for the development of clinical practice guidelines for the ,department of ,veterans ,affairs and the ,department of ,defense4 7c7 ,matters included ,in developing the clinical practice guidelines under subsection 7a71 the ,work ,group1 in consultation with the ,post ,traumatic ,stress ,disorder ,work ,group1 ,concussion-m,t,b,i ,work ,group1 ,opioid ,therapy for ,chronic ,pain ,work ,group1 and ,substance ,use ,work ,group1 shall ensure that the clinical practice guidelines include the following3 7#a7 ,guidance with respect to the following3 7,a7 ,the treatment of patients with post-traumatic stress disorder who are also experiencing a substance use disorder or chronic pain4 7,b7 ,the treatment of patients experiencing a mental health condition1 including anxiety1 depression1 or post-traumatic stress disorder as a result of military sexual trauma who are also experiencing a substance use disorder or chronic pain4 7,c7 ,the treatment of patients with traumatic brain injury who are also experiencing a substance use disorder or chronic pain4 7#b7 ,guidance with respect to the following3 7,a7 ,appropriate case management for patients experiencing post-traumatic stress disorder that is comorbid with substance use disorder or chronic pain who transition from receiving care while on active duty in the ,armed ,forces to care from health care networks outside of the ,department of ,defense4 7,b7 ,appropriate case management for patients experiencing a mental health condition1 including anxiety1 depression1 or post-traumatic stress disorder as a result of military sexual trauma that is comorbid with substance use disorder or chronic pain who transition from receiving care while on active duty in the ,armed ,forces to care from health care networks outside of the ,department of ,defense4 7,c7 ,appropriate case management for patients experiencing traumatic brain injury that is comorbid with substance use disorder or chronic pain who transition from receiving care while on active duty in the ,armed ,forces to care from health care networks outside of the ,department of ,defense4 7#c7 ,guidance with respect to the treatment of patients who are still members of the ,armed ,forces and are experiencing a mental health condition1 including anxiety1 depression1 or post-traumatic stress disorder as a result of military sexual trauma that is comorbid with substance use disorder or chronic pain4 7#d7 ,guidance with respect to the assessment by the ,national ,academies of ,sciences1 ,engineering1 and ,medicine of the potential overmedication of veterans1 as required pursuant to the ,senate report accompanying ,s4 #aeeg1 #aaeth ,congress 7,senate ,report #aae-acj71 under the heading ,overprescription ,prevention ,report under the heading ,,committee ,,recommendation4 7d7 ,rule of construction ,nothing in this section shall be construed to prevent the ,secretary of ,veterans ,affairs and the ,secretary of ,defense from considering all relevant evidence1 as appropriate1 in creating the clinical practice guidelines required under subsection 7a7 or from ensuring that the final clinical practice guidelines developed under such subsection and subsequently updated1 as appropriate1 remain applicable to the patient populations of the ,department of ,veterans ,affairs and the ,department of ,defense4 #c4 ,update of clinical practice guidelines for assessment and management of patients at risk for suicide by taking into consideration gender- and age-specific risk factors and gender- and age-specific treatment efficacy of pharmacotherapy and psychotherapy 7a7 ,in general ,not later than two years after the date of the enactment of this ,act1 the ,secretary of ,veterans ,affairs and the ,secretary of ,defense1 through the ,assessment and ,management of ,patients at ,risk for ,suicide ,work ,group 7in this section referred to as the ,work ,group71 shall issue an update to the ,,va_/,,dod ,clinical ,practice ,guideline for ,assessment and ,management of ,patients at ,risk for ,suicide4 7b7 ,matters included ,in carrying out the update under subsection 7a71 the ,work ,group shall ensure that the clinical practice guidelines updated under such subsection includes the following3 7#a7 ,enhanced guidance with respect to the following3 7,a7 ,gender- and age-specific risk factors for suicide and suicidal ideation4 7,b7 ,gender- and age-specific treatment efficacy for depression and suicide prevention4 7,c7 ,gender- and age-specific pharmacotherapy efficacy4 7,d7 ,gender- and age-specific psychotherapy efficacy4 7#b7 ,guidance with respect to the efficacy of alternative therapies1 other than psychotherapy and pharmacotherapy1 including the following3 7,a7 ,yoga therapy4 7,b7 ,meditation therapy4 7,c7 ,equine therapy4 7,d7 ,other animal therapy4 7,e7 ,training and caring for service dogs4 7,f7 ,agri-therapy4 7,g7 ,art therapy4 7,h7 ,outdoor sports therapy4 7,i7 ,music therapy4 7,j7 ,any other alternative therapy that the ,work ,group considers appropriate4 7#c7 ,guidance with respect to the findings of the ,creating ,options for ,veterans' ,expedited ,recovery ,commission 7commonly referred to as the ,,cover ,commission7 established under section #ica of the ,jason ,simcakoski ,memorial and ,promise ,act 7title ,,ix of ,public ,law #aad-aih2 #ch ,u4,s4,c4 #agja note74 7c7 ,rule of construction ,nothing in this section shall be construed to prevent the ,secretary of ,veterans ,affairs and the ,secretary of ,defense from considering all relevant evidence1 as appropriate1 in updating the ,,va_/,,dod ,clinical ,practice ,guideline for ,assessment and ,management of ,patients at ,risk for ,suicide1 as required under subsection 7a71 or from ensuring that the final clinical practice guidelines updated under such subsection remain applicable to the patient populations of the ,department of ,veterans ,affairs and the ,department of ,defense4